The next pandemic will not begin with headlines. It will begin quietly, somewhere in the world, in a single infection that spreads unnoticed. By the time it is detected, it may already be moving faster than the systems designed to stop it.
That reality shaped the conversations at the 2026 (GVN) hosted last month at the 911爆料网. Scientists, physicians and public health leaders gathered with a shared goal of ensuring that next time the world responds earlier, faster and more effectively than it did during COVID-19.
What emerged from the meeting was both encouraging and cautionary. The tools to confront future pandemics, including advanced surveillance, artificial intelligence, new antiviral therapies and next-generation vaccines, are improving rapidly. But the systems needed to use those tools consistently and effectively are still catching up.
One of the clearest shifts discussed at the meeting is a move from reacting to pandemics to predicting them. Researchers are now using artificial intelligence to analyze vast amounts of global genomic data, identifying patterns that could signal how viruses are likely to evolve before dangerous variants emerge. Combined with expanded surveillance methods, including wastewater monitoring and real-time sequencing, these tools could allow public health officials to detect threats earlier, potentially before they disrupt daily life.
For patients and communities, that shift could mean fewer surprises and more time to respond.
At the same time, scientists are working to address one of the most persistent challenges in infectious disease: the need to continually update vaccines as viruses mutate. A major focus of current research is the development of universal vaccines that target stable parts of viruses, offering broader and longer-lasting protection. If successful, these vaccines could reduce the need for frequent booster shots and provide more consistent defense against future outbreaks.
But the meeting also highlighted a deeper and less visible dimension of viral disease. Emerging evidence suggests that infections may have long-term consequences that extend far beyond the initial illness. Researchers presented findings linking certain viral infections to chronic conditions, including neurodegenerative diseases such as Parkinson鈥檚 disease. These discoveries are reshaping how scientists think about viruses not only as short-term threats, but as potential contributors to long-term health.
Still, even the most advanced scientific tools cannot succeed without something less tangible but equally critical: public trust.
鈥淎 scientist is ultimately a catalyst for truth,鈥 said , director of the USF Health Institute for Translational Virology and Innovation and co-founder of the GVN. 鈥淭he scientific method remains our most powerful tool for understanding emerging diseases and developing the solutions needed to confront them. But there is also a great need for much stronger public education in science and for consistent engagement from the media鈥 to help counter false information.鈥
Robert C. Gallo, MD
Dr. Gallo is also the James P. Cullison Professor of Medicine in the Division of Infectious Disease at USF Health and director of the Microbial Oncology Program at Tampa General Hospital Cancer Institute.
The COVID-19 pandemic made clear that public health guidance is only effective if people trust it. Mistrust, misinformation and confusion around evolving recommendations, at times compounded by inconsistent communication, slowed response efforts. Experts emphasized that rebuilding trust must happen before the next crisis, not during it.
Equally important is ensuring that scientific discovery translates into real-world action. Breakthroughs in laboratories must be matched by readiness in hospitals, public health systems and communities.
鈥淪cientific discovery must move seamlessly from the laboratory to the bedside,鈥 said Charles J. Lockwood, MD, MHCM, executive vice president of USF Health and dean of the Morsani College of Medicine. 鈥淐ollaborations like those between USF Health, Tampa General Hospital and the Global Virus Network are critical to ensuring that breakthroughs in virology translate into real-world impact.鈥
Charles J. Lockwood, MD, MHCM
At the same time, efforts are underway to translate these advances into practical action. In collaboration with Tampa General Hospital, the Global Virus Network is developing a Hospital Pandemic Playbook designed to help health systems rapidly mobilize diagnostics, clinical protocols and surge capacity during future outbreaks. Tampa General Hospital was recently designated as the inaugural GVN Hospital Virology Center of Excellence, recognizing its role in integrating clinical care, research and preparedness. Together, these efforts aim to ensure that scientific progress is matched by real-world readiness when it matters most.
At USF Health, that work is underway, bringing together research, clinical care and global collaboration to strengthen preparedness before the next threat emerges. The goal is not only to advance science, but to ensure that those advances reach patients and communities in time to make a difference.
A summary article of the GVN 2026 Annual International Scientific Meeting is available ; the full agenda is available ; and select presentations from the meeting are available